Halozyme Therapeutics, Inc. <HALO.O>: Leerink Partners raises to outperform from market perform; raises target price to $110 from $83
HALO•Related News
Firy publishes update to financial calendar
FIRY•
Cloudflare <NET.N>: Truist Securities raises target price to $350 from $300
NET•
Cognex Corporation <CGNX.O>: Truist Securities raises target price to $78 from $71
CGNX•
Alpha Metallurgical Resources Q2 Net Income USD -12.3 Million
AMR•
Array Digital Q2 revenue nearly doubles on site rental growth
AD•